News | MRI Breast | September 15, 2015

Komen Illinois Affiliates Applaud Rep. Smiddy on New Breast Cancer Law

BEST Act ensures quality screening and treatment options throughout state

Komen, Rep. Smiddy, BEST Act, breast cancer law, screening, MRI, Illinois

September 15, 2015 — The Susan G. Komen Illinois Affiliates applaud Rep. Mike Smiddy (D-Hillsdale) on the passage of the Breast Cancer Excellence in Survival and Treatment Act (BEST Act, HB3673) into law.

The new legislation acts as an amendment to the Illinois Insurance Code and the Illinois Public Aid Code as it relates to coverage and payment for screening by low-dose mammography for all women 35 years of age or older for the presence of occult breast cancer.

Key components of the new legislation include:

  • Requirement for all Medicaid health plans to include American College of Radiology Breast Centers of Imaging Excellence and Academic or Comprehensive Commission on Cancer Accredited centers in their networks, so that women can access the highest quality care;
  • Establishment of a breast cancer treatment quality program and expanded help to women diagnosed with breast cancer who are navigating the healthcare system; and
  • Ensuring medically necessary magnetic resonance imaging (MRI) screening as recommended by a licensed physician will be covered by insurance in Illinois.

The final version of the legislation passed both houses on May 31, and Illinois Gov. Bruce Rauner signed the bill into law on August 21.  

Sean Tenner, Komen Chicago's board president, began working with Rep. Smiddy over 18 months ago when Smiddy's wife, Deb, was fighting breast cancer.

"We applaud Representative Smiddy on his efforts to ensure Illinois women have access to necessary breast health services, and making breast cancer a top priority this past legislative session," Tenner noted.

For more information: www.ilga.gov/legislation

Related Content

Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging

Image courtesy of Imago Systems

News | Mammography | August 14, 2019
Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year...
Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses
News | Artificial Intelligence | August 13, 2019
University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that...
Lake Medical Imaging Selects Infinitt for Multi-site RIS/PACS
News | PACS | August 09, 2019
Infinitt North America will be implementing Infinitt RIS (radiology information system)/PACS (picture archiving and...
Volpara to Distribute Screenpoint Medical's Transpara AI Solution
News | Breast Imaging | August 02, 2019
Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint's Transpara...
Ikonopedia Releases Automated Combined Reporting Package at AHRA
News | Mammography Reporting Software | July 26, 2019
Ikonopedia showcased its recently released Automated Combined Reporting package and its entire suite of structured...
Hologic Partners With MagView to Develop Unifi EQUIP Solution
Technology | Mammography Reporting Software | July 25, 2019
Hologic announced a partnership with mammography information solutions provider MagView to develop Unifi EQUIP, an...
Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System
Technology | Breast Biopsy Systems | July 24, 2019
Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its...
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).